Literature DB >> 19776192

BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Adam S Coleman1, Utpal Pal.   

Abstract

One of the recently identified Borrelia burgdorferi immunogens, BBK07, is characterized for its expression in the spirochete infection cycle and evaluated for its potential use as a serodiagnostic marker for Lyme disease. We show that the BBK07 gene is expressed at extremely low levels in vitro and in ticks but is dramatically induced by spirochetes once introduced into the host and is highly expressed throughout mammalian infection. In contrast, the expression of BBK12, a paralog of BBK07 with 87% amino acid identity, although expressed in vitro, remained undetectable in vivo throughout murine infection and in ticks. BBK07 is localized in the outer membrane, and the amino-terminal domain of the antigen is exposed on the microbial surface. A truncated BBK07 protein representing the amino-terminal domain is able to effectively detect antibodies to B. burgdorferi, both in experimentally infected mice and in humans. Further characterization of the immunodominant antigens of B. burgdorferi, such as BBK07, could contribute to the development of novel serodiagnostic markers for detection of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776192      PMCID: PMC2772389          DOI: 10.1128/CVI.00301-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  53 in total

1.  Death from inappropriate therapy for Lyme disease.

Authors:  R Patel; K L Grogg; W D Edwards; A J Wright; N M Schwenk
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

2.  Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Authors:  F T Liang; E Aberer; M Cinco; L Gern; C M Hu; Y N Lobet; M Ruscio; P E Voet; V E Weynants; M T Philipp
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  Laboratory evaluation in the diagnosis of Lyme disease.

Authors:  P Tugwell; D T Dennis; A Weinstein; G Wells; B Shea; G Nichol; R Hayward; R Lightfoot; P Baker; A C Steere
Journal:  Ann Intern Med       Date:  1997-12-15       Impact factor: 25.391

4.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs.

Authors:  D T Gauthier; L S Mansfield
Journal:  J Vet Diagn Invest       Date:  1999-05       Impact factor: 1.279

6.  Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.

Authors:  L A Magnarelli; J W Ijdo; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

Authors:  M B Lawrenz; J M Hardham; R T Owens; J Nowakowski; A C Steere; G P Wormser; S J Norris
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis.

Authors:  Tero Heikkilä; Ilkka Seppälä; Harri Saxén; Jaana Panelius; Miikka Peltomaa; Tiina Julin; Sten-Anders Carlsson; Pekka Lahdenne
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

9.  TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi.

Authors:  Utpal Pal; Xin Li; Tian Wang; Ruth R Montgomery; Nandhini Ramamoorthi; Aravinda M Desilva; Fukai Bao; Xiaofeng Yang; Marc Pypaert; Deepti Pradhan; Fred S Kantor; Sam Telford; John F Anderson; Erol Fikrig
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

10.  Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Authors:  Rendi Murphree Bacon; Brad J Biggerstaff; Martin E Schriefer; Robert D Gilmore; Mario T Philipp; Allen C Steere; Gary P Wormser; Adriana R Marques; Barbara J B Johnson
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

View more
  9 in total

1.  Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine.

Authors:  Manish Kumar; Simarjot Kaur; Toru Kariu; Xiuli Yang; Ioannis Bossis; John F Anderson; Utpal Pal
Journal:  Vaccine       Date:  2011-09-21       Impact factor: 3.641

2.  Comprehensive Spatial Analysis of the Borrelia burgdorferi Lipoproteome Reveals a Compartmentalization Bias toward the Bacterial Surface.

Authors:  Alexander S Dowdell; Maxwell D Murphy; Christina Azodi; Selene K Swanson; Laurence Florens; Shiyong Chen; Wolfram R Zückert
Journal:  J Bacteriol       Date:  2017-02-28       Impact factor: 3.490

3.  BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.

Authors:  Adam S Coleman; Evelyn Rossmann; Xiuli Yang; Haichen Song; Chinta M Lamichhane; Radha Iyer; Ira Schwartz; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

4.  Antibody profiling of Borrelia burgdorferi infection in horses.

Authors:  Peter D Burbelo; Kathleen E Bren; Kathryn H Ching; Adam Coleman; Xiuli Yang; Toru Kariu; Michael J Iadarola; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2011-07-20

Review 5.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

6.  Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids.

Authors:  Sherwood R Casjens; Emmanuel F Mongodin; Wei-Gang Qiu; Benjamin J Luft; Steven E Schutzer; Eddie B Gilcrease; Wai Mun Huang; Marija Vujadinovic; John K Aron; Levy C Vargas; Sam Freeman; Diana Radune; Janice F Weidman; George I Dimitrov; Hoda M Khouri; Julia E Sosa; Rebecca A Halpin; John J Dunn; Claire M Fraser
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

7.  Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease.

Authors:  Samiksha Nayak; Archana Sridhara; Rita Melo; Luciana Richer; Natalie H Chee; Jiyoon Kim; Vincent Linder; David Steinmiller; Samuel K Sia; Maria Gomes-Solecki
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

8.  Experimental infections of the reservoir species Peromyscus leucopus with diverse strains of Borrelia burgdorferi, a Lyme disease agent.

Authors:  Elisabeth Baum; Fong Hue; Alan G Barbour
Journal:  mBio       Date:  2012-12-04       Impact factor: 7.867

9.  Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36.

Authors:  Michelle A Krupna-Gaylord; Dionysios Liveris; Andrea C Love; Gary P Wormser; Ira Schwartz; Mary M Petzke
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.